- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
NEW YORK ( TheStreet) -- SciClone Pharmaceuticals (Nasdaq: SCLN) hit a new 52-week high Monday as it is currently trading at $7, above its previous 52-week high of $6.97 with 296,592 shares traded as of 12:05 p.m. ET. Average volume has been 492,500 shares over the past 30 days. SciClone has a market cap of $385.1 million and is part of the health care sector and drugs industry. Shares are up 46.9% year to date as of the close of trading on Friday. SciClone Pharmaceuticals, Inc. provides therapies for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders in the People's Republic of China and internationally. The company has a P/E ratio of 11.9, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.